Paul Knight
Stock Analyst at Keybanc
(1.83)
# 3,176
Out of 5,182 analysts
141
Total ratings
44.44%
Success rate
-2.53%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Maintains: Overweight | $15 → $10 | $2.68 | +273.13% | 8 | Mar 11, 2026 | |
| STVN Stevanato Group | Maintains: Overweight | $37 → $32 | $16.24 | +97.04% | 6 | Mar 5, 2026 | |
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $466.70 | +60.70% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $309.70 | +13.01% | 12 | Oct 24, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $4.91 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $124.94 | +76.08% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $10.17 | +47.49% | 9 | Aug 6, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $6.78 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $52.20 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $311.20 | +47.81% | 5 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $0.89 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $2.25 | +255.56% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $87.15 | +66.38% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $141.66 | +196.48% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $107.71 | +113.54% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $21.72 | +51.93% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $23.69 | +51.96% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $178.57 | +73.60% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $114.06 | +92.88% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.45 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $3.03 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $114.42 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $25.11 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $7.76 | +415.46% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $167.74 | +78.85% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $160.68 | +55.59% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $136.65 | +222.72% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $124.76 | +89.16% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $64.95 | +52.42% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $24.71 | +122.58% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $33.15 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $96.89 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $125.44 | - | 5 | Oct 23, 2017 |
Exagen
Mar 11, 2026
Maintains: Overweight
Price Target: $15 → $10
Current: $2.68
Upside: +273.13%
Stevanato Group
Mar 5, 2026
Maintains: Overweight
Price Target: $37 → $32
Current: $16.24
Upside: +97.04%
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $466.70
Upside: +60.70%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $309.70
Upside: +13.01%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $4.91
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $124.94
Upside: +76.08%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $10.17
Upside: +47.49%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $6.78
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $52.20
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $311.20
Upside: +47.81%
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.89
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $2.25
Upside: +255.56%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $87.15
Upside: +66.38%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $141.66
Upside: +196.48%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $107.71
Upside: +113.54%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $21.72
Upside: +51.93%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $23.69
Upside: +51.96%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $178.57
Upside: +73.60%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $114.06
Upside: +92.88%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.45
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $3.03
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $114.42
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $25.11
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $7.76
Upside: +415.46%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $167.74
Upside: +78.85%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $160.68
Upside: +55.59%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $136.65
Upside: +222.72%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $124.76
Upside: +89.16%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $64.95
Upside: +52.42%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $24.71
Upside: +122.58%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $33.15
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $96.89
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $125.44
Upside: -